Ring vaccination may not be effective against monkeypox: Study
Published By : Prameya News Bureau | August 07, 2022 IST
Share
New Delhi, Aug 7 (IANS): Even as the health experts from around the globe have been stressing on the need to implement ring vaccination among the people at risk with monkeypox, a new study, not peer-reviewed yet, has claimed that the strategy may not be completely effective in curbing the current outbreak. Ring vaccination, which has been used successfully to contain smallpox and Ebola outbreaks, means to vaccinate a "ring" of people around the infected rather than vaccinating an entire population, ideally within four days of exposure. The study led by a team, including from Universite Paris Cite in France, showed that ring vaccination may not completely protect against infections. The findings were based on a third-generation smallpox vaccine recommended in France for individuals who had a high-risk contact with a PCR-confirmed Monkeypox patient. The study aimed to describe the outcomes of high-risk contacts receiving third-generation smallpox vaccine as an early post-exposure ring vaccination (EPRV) especially tolerance and potential breakthrough infections after the first dose. The team performed an observational analysis of all consecutive individuals vaccinated with the IMVANEX smallpox vaccine after a high-risk contact. It was defined as close skin-to-skin or mucosal contact and/or indirect contact on textile or surface and/or droplets exposure defined by a contact at less than 2 meters during at least 3 hours with a PCR-confirmed Monkeypox patient. Between May 27 and July 13, 276 individuals received one dose of IMVANEX with a median delay of 11 days after exposure with a confirmed Monkeypox patient. Mode of exposure was droplets for 240 patients (91 per cent), indirect contact for 189 (71 per cent) and unprotected sexual intercourse for 146 (54 per cent). Most of the patients were men (91 per cent) and men who have sex with men (88 per cent). The vaccine was well tolerated with no severe adverse event. Among the 276 vaccinated individuals, 12 (4 per cent) had a confirmed Monkeypox breakthrough infection with no severe infection. Ten out of 12 patients developed a Monkeypox infection in the five days following vaccination and two had a breakthrough infection at 22 and 25 days. "EPRV with a third-generation smallpox vaccine was well tolerated and effective against Monkeypox but did not completely prevent breakthrough infections," the researchers wrote in the paper posted online.
News7 Is Now On WhatsApp Join And Get Latest News Updates Delivered To You Via WhatsApp
You Might Also Like
More From Related News
Can't use 2011 ODI WC pics during campaign: ECI to Yusuf Pathan
BJP may announce candidates’ list for Odisha Assembly segments today
Government issues advisory against fraudulent calls impersonating DoT
Ukraine discusses peace formula with India
21 lakh sellers and service providers onboarded on GeM
Tech leaders hail PM Modi for his candid chat with Bill Gates
99% cases received through ECI's C-Vigil app resolved
NET scores to be used for PhD admissions: UGC
PM Modi's key lifestyle mantras for Bill Gates include super food millet, finding inner peace
India has democratised technology, aims to end digital divide: PM Modi
10 killed as cab plunges into deep gorge in J&K
Ayodhya gears up for ‘Ram Navami’ rush of devotees
BJP Core Committee meeting begins in Delhi: Likely to announce candidates for Odisha Assembly segments
Kharge hits back at PM Modi's 'bullying a Cong culture' remark
Mukhtar Ansari dies of cardiac arrest in Banda, security tightened in UP
Lawyers write to CJI over group trying to ‘pressurise judiciary’
Delhi horror: 5-year-old kidnapped, raped & killed; accused held
LS polls: 2.54 crore voters for Phase 1 in Rajasthan; 13 above 120 years of age
Big shock for BRS as Hyderabad Mayor decides to join Congress